Literature DB >> 10675414

Biochemical characterization of a hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequence.

L Tomei1, R L Vitale, I Incitti, S Serafini, S Altamura, A Vitelli, R De Francesco.   

Abstract

The RNA-dependent RNA polymerase activity of hepatitis C virus is carried out by the NS5B protein. The full-length protein was previously purified as a non-fusion protein from insect cells infected with a recombinant baculovirus. The characterization is now described of a C-terminal hydrophobic domain deletion mutant of NS5B purified from E. coli. In addition to increased solubility, deletion of this sequence also positively affected the polymerase enzymatic activity. The efficiency of nucleotide polymerization of both the full-length and the C-terminal truncated enzymes were compared on homopolymeric template-primer couples as well as on RNA templates with heteropolymeric sequences. The largest difference in the polymerase activity was observed on the latter. On all the templates, the increased activity could be ascribed, at least in part, to enhanced template turnover of the deletion mutant with respect to the full-length enzyme. The elongation rates of the two enzyme forms were compared under single processive cycle conditions. Under these conditions, both the full-length and the deletion mutant were able to incorporate about 700 nt/min.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675414     DOI: 10.1099/0022-1317-81-3-759

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Identification and functional characterization of the nascent RNA contacting residues of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Robert Vaughan; Baochang Fan; Jin-Sam You; C Cheng Kao
Journal:  RNA       Date:  2012-06-26       Impact factor: 4.942

2.  Efficiency of incorporation and chain termination determines the inhibition potency of 2'-modified nucleotide analogs against hepatitis C virus polymerase.

Authors:  Amy Fung; Zhinan Jin; Natalia Dyatkina; Guangyi Wang; Leo Beigelman; Jerome Deval
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

3.  Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells.

Authors:  Richard W Hardy; Joseph Marcotrigiano; Keril J Blight; John E Majors; Charles M Rice
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides.

Authors:  Licia Tomei; Sergio Altamura; Linda Bartholomew; Monica Bisbocci; Carolyn Bailey; Michele Bosserman; Antonella Cellucci; Eleonora Forte; Ilario Incitti; Laura Orsatti; Uwe Koch; Raffaele De Francesco; David B Olsen; Steven S Carroll; Giovanni Migliaccio
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

5.  Recombinant HCV NS3 and NS5B enzymes exhibit multiple posttranslational modifications for potential regulation.

Authors:  Sergio Hernández; Ariel Díaz; Alejandra Loyola; Rodrigo A Villanueva
Journal:  Virus Genes       Date:  2019-01-29       Impact factor: 2.332

6.  Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Anita Y M Howe; Johnathan Bloom; Carl J Baldick; Christopher A Benetatos; Huiming Cheng; Joel S Christensen; Srinivas K Chunduru; Glen A Coburn; Boris Feld; Ariamala Gopalsamy; William P Gorczyca; Steve Herrmann; Stephen Johann; Xiaoqun Jiang; Michelle L Kimberland; Girija Krisnamurthy; Matthew Olson; Mark Orlowski; Steve Swanberg; Ian Thompson; Megan Thorn; Alfred Del Vecchio; Dorothy C Young; Marja van Zeijl; John W Ellingboe; Janis Upeslacis; Marc Collett; Tarek S Mansour; John F O'Connell
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

7.  Effects of mutagenic and chain-terminating nucleotide analogs on enzymes isolated from hepatitis C virus strains of various genotypes.

Authors:  Julie A Heck; Angela M I Lam; Nirupama Narayanan; David N Frick
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

8.  cis-acting RNA signals in the NS5B C-terminal coding sequence of the hepatitis C virus genome.

Authors:  Haekyung Lee; Hyukwoo Shin; Eckard Wimmer; Aniko V Paul
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.

Authors:  Ginette McKercher; Pierre L Beaulieu; Daniel Lamarre; Steven LaPlante; Sylvain Lefebvre; Charles Pellerin; Louise Thauvette; George Kukolj
Journal:  Nucleic Acids Res       Date:  2004-01-22       Impact factor: 16.971

10.  Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Licia Tomei; Sergio Altamura; Linda Bartholomew; Antonino Biroccio; Alessandra Ceccacci; Laura Pacini; Frank Narjes; Nadia Gennari; Monica Bisbocci; Ilario Incitti; Laura Orsatti; Steven Harper; Ian Stansfield; Michael Rowley; Raffaele De Francesco; Giovanni Migliaccio
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.